Assembly Biosciences

IPO

Home - Assembly Bio

Assembly Biosciences was founded in 2012, is headquartered in South San Francisco, United States, lists 51–200 employees, and has $217.7M in recorded funding across 3 rounds.

Employees
51–200
Founded
2012
Business Model
B2B
Total Funding
$217.7M
Last Round
$175.0M Venture RoundAug 2025
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 7 investors for this company. The full record is or through the API.

About

Assembly Biosciences is a clinical-stage biotechnology company dedicated to developing innovative small-molecule antiviral therapeutics targeting serious viral diseases. The company's pipeline focuses on recurrent genital herpes, chronic hepatitis delta virus (HDV), and chronic hepatitis B (HBV). Assembly Bio partners with Gilead Sciences to advance novel antiviral treatments with the potential to change disease outcomes for patients worldwide.

Summary

Assembly Biosciences is a Biotech company based in South San Francisco, United States, founded in 2012. It lists 51–200 employees. It has raised $217.7M in total across 3 rounds, most recently a $175.0M Venture Round in Aug 2025. Investors include Gilead Sciences, Armistice Capital and Commodore Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundAug 2025
$175.0M

Sign up to see all 3 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Assembly Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/assembly-biosciences"><img src="https://indexed.vc/api/badge/company/assembly-biosciences" alt="Assembly Biosciences on Indexed.vc" width="260" height="76" /></a>